Safety concerns with the popular birth control pill Yaz increased Thursday as federal health scientists reported that the Bayer drug and other newer birth control treatments appear to increase the ...
Yaz, Yasmin and other newer birth control pills will soon be bearing warning labels that detail the potential risk of blood clot risks, the U.S. Food and Drug Administration (FDA) announced on Tuesday ...
The Food and Drug Administration's panel of experts voted 21-5 Thursday that labeling on the popular drugs made by Bayer is inadequate and needs more information about the potential risk of blood ...
No rest for the Food and Drug Administration (FDA) this week. In addition to considering broadened access to the emergency contraceptive Plan B, an FDA panel decided on Thursday to update labeling on ...
Birth control pills such as Yasmin and Yaz may be associated with up to three times the risk of blood clots compared with other oral contraceptives, according to a Health Canada review. The department ...
The new labeling will apply to Bayer's Yaz, its predecessor Yasmin and similar drugs that have the manmade hormone called drospirenone, which mimics the naturally occurring female hormone progesterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results